Greenwich Time

DeLauro plays key role in NAFTA talks

- By Ana Radelat CTMIRROR.ORG

WASHINGTON — When Rep. Rosa DeLauro and some of her congressio­nal colleagues tried to visit a Goodyear plant in Mexico this summer, she was surprised to be denied entry into the facility.

“We were all disappoint­ed that we were not able to talk to the workers at the Goodyear facility in San Luis Potosi,” said DeLauro, DConn. “Now Goodyear is an American company … we deserve the opportunit­y to see the condition of the workers in their plant.”

The reason DeLauro wanted to see how labor is being treated in Mexico?

“If workers’ rights are not being upheld (in Mexico) that undercuts worker’s rights and wages here,” she said.

DeLauro is part of a team of House Democrats negotiatin­g with the White House over a new trade pact with Canada and Mexico that would replace the 25yearold North American Free Trade Agreement, or NAFTA. House Speaker Nancy Pelosi, DCalif., chose the members of the negotiatin­g team, which also includes Rep. John Larson, DConn.

De Lauro’s role on the ninemember team is to ensure the enforcemen­t mechanisms of the new treaty, called the United StatesMexi­coCanada Agreement, or USMCA, are effective. But she also has an outsized role in determinin­g what the final deal will be.

No one doubts DeLauro is a tough negotiator.

DeLauro opposed NAFTA and pushed to sink the now defunct TransPacif­ic Partnershi­p, or TPP, that would have allied the United States with Pacific Rim nations to counter China’s economic strength.

She said a trade treaty’s impact on labor and middleclas­s Americans “is very important to me.”

“This has been the crux of my role in trade issues,” DeLauro said.

A friend of organized labor who fought NAFTA , the TPP and other trade pacts, DeLauro met with some of the workers who had been fired at the Goodyear plant in San Luis Potosi. That meeting took place after she was denied entry into the facility.

She and several other Democrats wrote Goodyear president and CEO Richard Kramer they were “disappoint­ed that an iconic American company like Goodyear, which is shedding jobs at home while building new facilities in Mexico, is failing to provide its workers in Mexico with basic labor rights that are recognized internatio­nally and under Mexican law.”

The letter also accused Goodyear of poor working conditions and paying less than $2 per hour to junior workers at its San Luis Potosi plant and just over $6 to the highestpai­d workers.

“So, it was a good trip … but it left us with serious concerns which we are trying to address,” DeLauro said.

Goodyear said it “strongly disagreed” with the statements the lawmakers made about the working conditions and labor practices at the plant.

In a statement, Goodyear also said it “regrets that it was unable to accommodat­e a tour for the congressio­nal delegation.

“The company was unclear on a number of details about the visit, including the timing,” the company said.

Fears of slacker worker, environmen­tal standards

The concerns about the USMCA voiced by trade skeptics like DeLauro were also raised when NAFTA, the TPP and other trade pacts were negotiated. They center on fears the agreements may lead to looser U.S. environmen­tal standards and weaker worker protection­s.

“A revised NAFTA deal, which was signed in 2018, showed some improvemen­t,” DeLauro said. “But their labor and environmen­tal terms and their enforcemen­t mechanisms are too weak to stop the American job loss. If the current deal were signed and enacted, we would continue to have American jobs moving to Mexico, where they pay workers less.”

Organized labor has not rejected the USMCA, however, and the AFLCIO is sending a delegation to Mexico to discuss the proposed treaty this week.

Another concern is the USMCA’s impact on drug prices, especially for the most expensive medicine on the market — biologic drugs.

Biologic medicines are produced from living cells that contain proteins and other materials that can treat diseases and conditions like cancer, rheumatoid arthritis and multiple sclerosis.

“Biosimilar” medicines are the generic form of biologic drugs. Lawmakers have for years tried to shorten the exclusivit­y period pharmaceut­icals have that would allow less expensive biosimilar­s to come to market more quickly.

But a draft of the USMCA would grant at least a 10year “test data” exclusivit­y period for new biologics. Currently, Canada has an eightyear test data exclusivit­y period and Mexico has a fiveyear limit, so the USMCA would force both countries to increase this period and make it harder for the United States to shorten its exclusivit­y period.

“You also have an expansion of the definition of biologics,” DeLauro said. “We need to get changes in the agreement.”

Meanwhile, the Trump administra­tion has been touting the economic benefits of the USMCA, which many call NAFTA 2.0.

Larry Kudlow, director of the White House National Economic Council, said the new trade pact “would add half a point to the GDP and 180,000 jobs per year if we get it through.”

After China, Mexico and Canada are the United States’ largest trading partners.

Connecticu­t’s economy also depends on foreign trade. According to the office of the U.S. Trade Representa­tive, the state exported about $2 billion in goods to Canada and $948 million to Mexico in 2018.

Despite her misgivings DeLauro, who met with Mexican President Andrés Manuel López Obrador and other Mexican officials during her trip to that country in July, is optimistic the USMCA can be changed in such a way Congress could approve the treaty.

“We are working together with (U.S. Trade Representa­tive) Bob Lighthizer to make changes to the renegotiat­ed NAFTA,” DeLauro said. “I would characteri­ze the meetings and the conversati­ons as productive.”

Under an agreement approved by Congress in 2015, the USMCA would be “fast tracked” by Congress.

That means Congress would have no more than 90 days after the treaty is officially introduced by President Donald Trump to have up or down votes in the House and Senate on the USMCA. No amendments to the final treaty negotiated with Mexico and Canada would be allowed.

The GOPled Senate is expected to approve the trade pact. But the USMCA faces problems in the Democratic House.

That’s why Pelosi created the USMCA working group to which De Lauro and Larson belong, said Vanessa Sciarra, vice president of the National Foreign Trade Council.

Sciarra said Pelosi “was very smart” in choosing both members of the House Progressiv­e Caucus, like DeLauro, and member of the moderate New Democrat Coalition, to negotiate with the White House over a final treaty.

“She wanted to make sure that all Democrats were heard,” Sciarra said.

Time running out

Larson was chosen as one off our members on the working group who sit on the House Ways and Means Committee, which has jurisdicti­on over trade issues.

“House Democrats have been pushing the administra­tion to ensure that the renegotiat­ed NAFTA has strong and enforceabl­e labor and environmen­t standards and preserves access to affordable medicines,” Larson said “The working group has had constructi­ve meetings with Ambassador Lighthizer and we look forward to making progress on the substance of the agreement as the negotiatio­ns continue.”

At least 60 Democrats must join the vast majority of House Republican­s to be able to approve the treaty.

Sciarra said it’s not likely Trump will send a final treaty over until Pelosi has the votes to approve it.

Vice President Mike Pence has been dispatched across the country in an attempt to force vulnerable House Democrats to hurry along ratificati­on of the USMCA.

Time, Pence told reporters at the end of July, was already running out.

But DeLauro said approval of the treaty is likely to “seep into next year.”

 ?? Brian A. Pounds / Hearst Connecticu­t Media ?? U.S. Rep. Rosa DeLauro
Brian A. Pounds / Hearst Connecticu­t Media U.S. Rep. Rosa DeLauro

Newspapers in English

Newspapers from United States